Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

Crohns Disease is a chronic inflammatory bowel condition that primarily affects the digestive tract but can also cause ...

Learn about the key symptoms of Crohn’s Disease and its impact on daily life. Early diagnosis is essential for effective ...

Results of a Phase III study conducted by an international team of researchers reveal that mirikizumab is more effective and ...

67% of employees wish their workplace offered benefits for GI health.

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative ...

In fact, as many as 35% of people with IBD have some kind of oral manifestation of the condition, such as canker sores, the ...

Inflammatory bowel disease (IBD) is a chronic inflammation of the digestive tract. It includes conditions such as ulcerative ...

Yesintek, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis and ...

During Crohn’s and Colitis Awareness Week, organisations from all over the globe come together to raise vital awareness.

The SELECTION study1 showed that the JAK 1 inhibitor filgotinib is safe and efficacious in ulcerative colitis. Based on positive results of the phase 2 FITZROY study2 in Crohn's disease, it was ...